new pub from the lab describing a strategy for caging amidated peptides (most neuropeptides); applied to CCK, oxytocin, substance P, and GRP pubs.acs.org/doi/10.1021/jac… congrats to all authors, incl. @XIANGMa13@jennyxinyi & 1st author aryanna layden, now starting her PhD at Berkeley
It's clear that many do not understand what @NIH-funded research does to improve health. It's time to revive a study published 10 years ago that provides incredible information about this. link in the comment
Every single new drug approved by the FDA from 2010–2016 was built on NIH-funded research—that’s all 210 drugs. But what the public sees is just the tip of the iceberg.
Pharma takes credit for the final product, but beneath each drug developed, there are ~20 years of basic research, and 90% of the cost is from basic research funded by the NIH, which discovers drug targets, understands disease mechanisms, and creates life-saving treatments.
Figuring out how cancer evades the immune system, how addiction rewires the brain, and how heart disease develops is the role of the NIH, creating the foundation for the breakthrough drugs that come 20 years later, and the NIH does all that with only 0.8% of the US budget.
Without NIH, there would be no cancer immunotherapy, no anti-overdose medication, no anti-heart attack or stroke medication, no cutting-edge treatments.
If NIH funding is cut, the iceberg will melt. That means fewer cures, more suffering, and more lives lost.
The science beneath the surface keeps us afloat.
Invest in NIH. Invest in life
Curious about the placebo effect, especially placebo pain relief? If so, check out our pre-print on placebo analgesia in mice bit.ly/3QlktPq, in which we ask how pain-modulatory neural circuits become activated in the brain to suppress pain in the absence of a drug. 1/9
Understanding the neural basis of placebo will help us develop better therapies for pain and depression. Capitalizing on placebo can reduce our reliance on dangerous drugs, whereas reducing placebo in clinical trials will help reveal the true efficacy of emerging therapies. 9/9
Our findings suggest that the vlPAG is a central node in a closed, negative feedback loop through which incoming noxious sensory information is shaped by endogenous opioids to match expectations based on prior experience. 7/
Using in vivo photopharmacology, we locally photo-activated PhNX, our “caged” naloxone bit.ly/4b2XTEI, to establish that this rapidly evoked opioid peptide signaling in the vlPAG is necessary for placebo pain relief. 6/9
Using a genetically-encoded opioid sensor developed by @LinTianPhDbit.ly/4i2jHTf, we discovered that the painful test stimulus evokes opioid peptide release in the vlPAG within seconds, but this was only detected after morphine conditioning. 5/9
Using Ca2+ recordings and LOF manipulations, we established an essential role for vlPAG neurons that project to the RVM in both morphine and placebo analgesia. In contrast, we found that cortical input to the vlPAG is only critical for placebo. 4/9
Although we only conditioned the mice to suppress a paw withdrawal (antinociception), the placebo effect extended to unconditioned pain-related behaviors, such as avoidance and escape, indicating that the conditioning protocol produces a general state of analgesia. 3/9
To achieve placebo analgesia in mice, we conditioned them with morphine. This yielded ~50% of the morphine effect on placebo trials! Like most placebo analgesia in humans, the placebo in mice relies on endogenous opioid neuropeptide signaling. 2/9
Read about the latest circuit tools for studying neuromodulator & neuropeptide signaling in vivo!
We describe the use of neurochemical sensors, actuators, and probes in our lab’s first Review @ScienceMagazinetinyurl.com/4mcfb24w
Congrats @jessie_muir & @LatinaNeuroNerd!
1/6 Exciting news! Our paper is now online in @CellCellPress! We've developed PRESYNAPTIC sensor and silencer for peptidergic transmission. The sensor detects LDCV release events, and the silencer specifically degrades neuropeptides inside the LDCV. authors.elsevier.com/a/1jTSj…